Optimized intrapleural cisplatin chemotherapy with a fibrin carrier after extrapleural pneumonectomy: A preclinical study

Journal of Thoracic and Cardiovascular Surgery

Volumn 141, Issue 1, 2011, Pages 65-71

  Opitz, Isabelle ^a   Erne, Barbara V ^a   Demirbas, Seval ^a   Jetter, Alexander ^a   Seifert, Burkhardt ^b   Stahel, Rolf ^a   Weder, Walter ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

analysis of variance; ANOVA; CDDP; CI; cisplatin; coefficient of variation; confidence interval; CV

Indexed keywords

CISPLATIN; CREATININE; FIBRIN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG TISSUE LEVEL; LUNG CANCER; LUNG RESECTION; NONHUMAN; PLEURECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SWINE; UREA BLOOD LEVEL;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CREATININE; DRUG ADMINISTRATION ROUTES; DRUG CARRIERS; FIBRIN TISSUE ADHESIVE; MODELS, ANIMAL; PLEURAL CAVITY; PNEUMONECTOMY; SPECTROPHOTOMETRY, ATOMIC; SUS SCROFA; THORACIC WALL; TISSUE DISTRIBUTION;

EID: 78650271623     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.09.032     Document Type: Article

References (19)

1. L.M. Krug, H.I. Pass, V.W. Rusch, H.L. Kindler, D.J. Sugarbaker, and K.E. Rosenzweig Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma J Clin Oncol 27 2009 3007 3013
2. W. Weder, R.A. Stahel, J. Bernhard, S. Bodis, P. Vogt, and P. Ballabeni Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma Ann Oncol 18 2007 1196 1202
3. L. Zellos, W.G. Richards, L. Capalbo, M.T. Jaklitsch, L.R. Chirieac, and B.E. Johnson A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma J Thorac Cardiovasc Surg 137 2009 453 458
4. W.G. Richards, L. Zellos, R. Bueno, M.T. Jaklitsch, P.A. Janne, and L.R. Chirieac Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma J Clin Oncol 24 2006 1561 1567
5. V. Rusch, L. Saltz, E. Venkatraman, R. Ginsberg, P. McCormack, and M. Burt A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma J Clin Oncol 12 1994 1156 1163
6. M.Y. Chang, and D.J. Sugarbaker Innovative therapies: intraoperative intracavitary chemotherapy Thorac Surg Clin 14 2004 549 556
7. J.D. Lee, S. Perez, H.J. Wang, R.A. Figlin, and E.C. Holmes Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: the UCLA experience J Surg Oncol 60 1995 262 267
8. M. Colleoni, F. Sartori, F. Calabro, P. Nelli, G. Vicario, and G. Sgarbossa Surgery followed by intracavitary plus systemic chemotherapy in malignant pleural mesothelioma Tumori 82 1996 53 56
9. T.W. Rice, D.J. Adelstein, T.J. Kirby, M.G. Saltarelli, S.R. Murthy, and M.A. Van Kirk Aggressive multimodality therapy for malignant pleural mesothelioma Ann Thorac Surg 58 1994 24 29
10. T.R. Tilleman, W.G. Richards, L. Zellos, B.E. Johnson, M.T. Jaklitsch, and J. Mueller Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study J Thorac Cardiovasc Surg 138 2009 405 411
11. V.W. Rusch, D. Niedzwiecki, Y. Tao, C. Menendez-Botet, A. Dnistrian, and D. Kelsen Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies J Clin Oncol 10 1992 1001 1006
12. D. Lardinois, F.J. Jung, I. Opitz, K. Rentsch, C. Latkoczy, and V. Vuong Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma J Thorac Cardiovasc Surg 131 2006 697 703
13. I. Opitz, D. Lardinois, S. Arni, S. Hillinger, P. Vogt, and B. Odermatt Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment Eur J Cardiothorac Surg 31 2007 773 778
14. M. Bettinelli ICP-MS determination of Pt in biological fluids of patients treated with antitumor agents: evaluation of analytical uncertainty Microchem J 79 2005 357 365
15. S. Zimmermann, C.M. Menzel, Z. Berner, J.-D. Eckhardt, D. Stüben, and F. Alt Trace analysis of platinum in biological samples: a comparison between sector field ICP-MS and adsorptive cathodic stripping voltammetry following different digestion procedures Anal Chim Acta 439 2001 203 209
16. H. Take, K. Kubota, K. Tamura, H. Kurabayashi, T. Shirakura, and S. Miyawaki Activation of circulating platelets by hyperthermal stress Eur J Med Res 1 1996 562 564
17. E.G. Pivalizza, S.M. Koch, U. Mehlhorn, J.M. Berry, and J.M.C. Bull The effects of intentional hyperthermia on the Thrombelastograph and the Sonoclot analyser Int J Hyperthermia 15 1999 217 223
18. K. Tamura, K. Kubota, H. Kurabayashi, and T. Shirakura Effects of hyperthermal stress on the fibrinolytic system Int J Hyperthermia 12 1996 31 36
19. E.H. Baldini, A. Recht, G.M. Strauss, M.M. DeCamp Jr., S.J. Swanson, and M.J. Liptay Patterns of failure after trimodality therapy for malignant pleural mesothelioma Ann Thorac Surg 63 1997 334 338